More reads
- Federal judge blocks Trump rule to require drug prices in TV ads (STAT)
- Takeda, already a giant in Mass. biopharma, plans a bigger footprint. (STAT Plus)
- How phenylketonuria, a once-neglected disease, became a proving ground for new drugs. (Chemical & Engineering News)
- Rare disease biotech Fulcrum Therapeutics sets terms for $77 million IPO. (Nasdaq)
No hay comentarios:
Publicar un comentario